GARDP 165d ago

GARDP Webinar, broadcast on 15 January 2026 In 2019, GARDP launched “5 BY 25”, an initiative to develop five new antibiotic treatments during the period 2020-2025. Part of a broader strategy, 5 BY 25 signaled GARDP’s ambition to develop its R&D and access portfolio and expand its role in global efforts to counter antibiotic resistance. This webinar took stock of what GARDP accomplished and learned over the past five years, and how it is leveraging progress to advance sustainable antibiotic R&D and access focused on public health needs. Speakers: Anand Anandkumar – Bugworks Manica Balasegaram – GARDP Glenda Gray – SAMRC & Wits University David Paterson – ADVANCE-ID Moderator: Herman Goossens – University of Antwerp GARDP's 5By25 Report is available here: https://gardp.org/publications/gardps-5by25-report-laying-the-foundation-for-sustainable-antibiotic-rd-and-access/ GARDP: https://www.gardp.org/ REVIVE: https://revive.gardp.org/ #webinar #GARDP #5by25 #antibiotics #antibioticresistance #amr